Bangladesh

in page functions
[French]
Bangladesh
Total population (2017) 164,819,455
Birth cohort (2017) 3,095,451
Surviving Infants (surviving to 1 year per year, 2017) 3,014,717
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 31/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 38/1000
World Bank Index, IDA (2015) 3.31
Gross Nation Income (per capita US$, 2015) 1,190
Co-financing group (2018) Preparatory transition
No. of districts/territories (2016) 64

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Bangladesh

Type of support

Approvals

2001-2022 (US$)
(25 Apr 2018)

Commitments

2001-2022 (US$)
(25 Apr 2018)

Disbursements

2000-2018 (US$)
(25 Apr 2018)

% Disbursed

(25 Apr 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total $629,943,834 $629,968,834 $590,326,333
Cash Support (CASHSUPP) $333,500 $358,500 $333,500 100%
Health system strengthening (HSS 1) $13,671,500 $13,671,500 $13,671,500 100%
Health system strengthening (HSS 2) $37,922,731 $37,922,731 $22,889,726 60%
HepB mono (NVS) $20,224,465 $20,224,465 $20,224,465 100%
HPV Demo (NVS) $715,990 $715,990 $716,562 100%
Immunisation services support (ISS) $23,340,200 $23,340,200 $23,340,200 100%
Injection Safety Devices (NVS) $3,382,000 $3,382,000 $4,021,464 119%
Injection safety support (INS) $6,144,414 $6,144,414 $6,144,414 100%
IPV (NVS) $14,697,810 $14,697,810 $12,050,430 82%
IPV Catch-up RI (NVS) $1,433,500 $1,433,500
Measles (NVS) $9,702,862 $9,702,862 $9,740,021 100%
Measles-Rubella (NVS) $36,040,812 $36,040,812 $35,781,812 99%
MR - Operational costs (OPC) $33,586,500 $33,586,500 $33,586,500 100%
MR 1st and 2nd dose (NVS) $80,000 $80,000
Operational costs (OPC) $451,257 $451,257 $451,257 100%
Penta (NVS) $238,450,607 $238,450,607 $242,874,143 102%
Pneumo (NVS) $174,199,971 $174,199,971 $156,186,339 90%
Product Switch Grant (PSG) $279,715 $279,715
Rotavirus (NVS) $4,275,500 $4,275,500
Vaccine Introduction Grant (VIG) $11,010,500 $11,010,500 $8,314,000 76%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Bangladesh DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 94%
M:F sex ratio at birth (2017) 1.05
Household survey: DTP3 coverage for male (2013) 90.40%
Household survey: DTP3 coverage for female (2013) 92.30%
Household survey: Last DTP3 survey (2013) 91%
% districts achieving > 80% DTP3 coverage (2016) 100%
% districts achieving < 50% DTP3 coverage (2016) 0%
MCV WHO/UNICEF estimates (2016) 94%

Breakdown of support

Non-vaccine support Vaccine support
18% 82%
$108,731,097 $481,595,236

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Bangladesh

07 May 2018

Zambian children

Largest cholera vaccine drive in history to target spike in outbreaks

Two million people in five African countries to be protected against cholera.

03 April 2018

Typhoid vaccination in Nepal

New typhoid vaccine to receive Gavi support

Gavi has earmarked US$ 85 million to fund the introduction of the vaccine in the world’s poorest countries.

05 February 2018

Rohingya refugee camps: diphtheria outbreak sends warning to all countries

Since November 2017, there have been around 5,000 suspected cases of diphtheria among the Rohingya refugees sheltering at Cox’s Bazar in eastern Bangladesh after fleeing their native Myanmar. In humanitarian crises, disease is often the first emergency but this outbreak took aid workers by surprise.

close icon

modal window here